Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 1
1986 1
1990 1
1999 1
2006 4
2007 1
2008 1
2011 1
2012 66
2013 2
2014 4
2015 8
2016 6
2017 13
2018 18
2019 9
2020 11
2021 16
2022 17
2023 12
2024 9
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Similar articles for PMID: 31643958

131 results

Results by year

Filters applied: . Clear all
Page 1
Nitisinone.
[No authors listed] [No authors listed] 2016 Oct 5. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. 2016 Oct 5. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. PMID: 31643958 Free Books & Documents. Review.
Clinical Review Report: Nitisinone (MDK-Nitisinone): (MendeliKABS Inc.): Indication: For the treatment of patients with hereditary tyrosinemia type 1 in combination with dietary restriction of tyrosine and phenylalanine [Internet].
[No authors listed] [No authors listed] Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2018 Apr. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2018 Apr. PMID: 30457782 Free Books & Documents. Review.
Clinical Review Report: Nitisinone (Nitisinone Tablets): (Cycle Pharmaceuticals Ltd.): Indication: For the treatment of patients with hereditary tyrosinemia type 1 in combination with dietary restriction of tyrosine and phenylalanine [Internet].
[No authors listed] [No authors listed] Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2018 Aug. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2018 Aug. PMID: 30973686 Free Books & Documents. Review.
Clinical Review Report: Nitisinone (Orfadin): (Sobi Canada Inc.): Indication: For the treatment of patients with hereditary tyrosinemia type 1 in combination with dietary restriction of tyrosine and phenylalanine [Internet].
[No authors listed] [No authors listed] Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2018 Apr. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2018 Apr. PMID: 30457777 Free Books & Documents. Review.
131 results